The Times Group's ET NOW Global Business Summit (GBS) returns for its 9th edition, solidifying its position as Asia's premier ...

Strategic partnership aimed at combining advisory and technical expertise to empower organizations in Saudi Arabia and the ...

Collaboration will deliver integrated enterprise solutions, enhancing operational efficiency and business growth across key ...

Recently, the firm has been leaning into its scale-driven cost advantage to emphasize its value offerings amid a challenging consumption spending environment. We view this strategy as prudent.

Eco Wave Power, which will finish its Port of LA installation soon, has teased a pilot project planned for Maharashtra, India ...

Union Minister Nityanand Rai says, "Today I met the Prime Minister along with all the NDA MPs. PM Modi's blessings are always ...

Hansa Biopharma AB (HNSBF) reports a robust 35% increase in IDEFIRIX sales and expands its European market presence, despite facing revenue fluctuations and operating losses.

Management projected strong growth for 2025, driven by expanded reimbursement in key European markets such as Spain and Italy and the expected completion of the post-approval efficacy study (PAES).

IDEFIRIX Product Sales Increased 83% Compared to the Prior Year LUND, Sweden, Feb. 6, 2025 /PRNewswire/ -- Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced ...

Hansa Biopharma AB, Hansa or the Company (Nasdaq Stockholm: HNSA) today announced its full year and Q4 2024 financial results. Søren ...

Apartment management company MAA has a leasing and property management job fair coming up Thursday in Durham. Dr. Tara Narula ...